WA
ABBV icon

Westfuller Advisors’s AbbVie ABBV Stock Holding History

Westfuller Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Sell
543
-934
-63% -$207K 0.05% 184
2025
Q4 		$338K Buy
1,477
+579
+64% +$132K 0.14% 108
2025
Q3 		$208K Buy
+898
New +$183K 0.09% 145

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfuller Advisors's ABBV Position: Q1 2026 in Review

Westfuller Advisors reduced its AbbVie (ABBV) stake by 63% in Q1 2026, selling an estimated $207K and leaving 543 shares worth $118K. The position accounts for 0.05% of the portfolio, ranked #184.

Westfuller Advisors first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. The position peaked at $338K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Westfuller Advisors held 543 shares of AbbVie worth $118K as of Q1 2026.
  • Westfuller Advisors sold 934 AbbVie shares in Q1 2026, an estimated $207K.
  • AbbVie made up 0.05% of Westfuller Advisors's portfolio in Q1 2026, its #184 holding.
  • Westfuller Advisors first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's AbbVie position peaked at $338K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.